Abstract
There is growing evidence suggesting that certain interventions during the perioperative period may have an impact on long-term outcomes of patients undergoing cancer surgery. It has been postulated that regional anesthetic techniques and other targeted interventions could decrease the risk of cancer recurrence, therefore increasing the disease-free interval and overall survival, of those patients undergoing cancer surgery. Conversely, however, it has also been theorized that volatile anesthetics, opioids and surgery itself are directly or indirectly linked to cancer recurrence. Among the opioids used during the perioperative period, morphine has raised most of the concerns regarding its putative effects on cancer. Indeed, morphine has been found to affect many cellular and cell signaling pathways involved in cancer genesis and possibly causing tumor growth. This chapter will focus on the role of the perioperative period on cancer progression, the recognized mechanisms of action of morphine on cancer and alternative pain management options for patients undergoing cancer surgery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- cAMP:
-
cyclic adenosine monophosphate
- COX-2:
-
cyclooxygenase 2
- HIF:
-
hypoxia inducible transcription factor
- NK:
-
natural killer
- NO:
-
nitric oxide
- NSAIDs:
-
non-steroidal anti-inflammatory drugs
- PMN:
-
polymorphonuclear leucocyte
- PGE2:
-
prostaglandin E2
- STAT-3:
-
signal transducer of activation and transcription-3
- VEGF:
-
vascular endothelial growth factor
References
Afsharimani B, Cabot PJ, Parat MO (2011) Morphine use in cancer surgery. Front Pharmacol 2:46
Amato A, Pescatori M (2006) Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev 1:CD005033. doi:10.1007/BF02235262
Anderson SK (2005) Biology of natural killer cells: what is the relationship between natural killer cells and cancer? Will an increased number and/or function of natural killer cells result in lower cancer incidence? J Nutr 135(12):2910S
Azuma Y, Shinohara M et al (2000) Comparison of inhibitory effects of local anesthetics on immune functions of neutrophils. Int J Immunopharmacol 22(10):789–796
Bar-Yosef S, Melamed R, Page GG et al (2001) Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats. Anesthesiology 94:1066–1073
Beilin B, Martin FC, Shavit Y et al (1989) Suppression of natural killer cell activity by high-dose narcotic anesthesia in rats. Brain Behav Immun 3:129–137
Beilin B, Shavit Y, Hart J et al (1996) Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period. Anesth Analg 82:492–497
Ben-Eliyahu S (2003) The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology. Brain Behav Immun 17(Suppl 1):S27–S36
Ben-Eliyahu S, Shakhar G, Rosenne E et al (1999) Hypothermia in barbiturate-anesthetized rats suppresses natural killer cell activity and compromises resistance to tumor metastasis: a role for adrenergic mechanisms. Anesthesiology 91:732–740
Benish M, Bartal I, Goldfarb Y et al (2008) Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann Surg Oncol 15:2042–2052
Biki B, Mascha E, Moriarty DC et al (2008) Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology 109:180–187
Bone RC (1996) Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med 125:680–687
Bornemann-Cimenti H, Lederer AJ, Wejbora M et al (2012) Preoperative pregabalin administration significantly reduces postoperative opioid consumption and mechanical hyperalgesia after transperitoneal nephrectomy. Br J Anaesth 108:845–849
Brittenden J, Heys SD, Ross J, Eremin O et al (1996) Natural killer cells and cancer. Cancer 77:1226–1243
Bruzzone A, Pinero CP, Castillo LF et al (2008) Alpha2-adrenoceptor action on cell proliferation and mammary tumour growth in mice. Br J Pharmacol 155:494–504
Cadet P, Mantione KJ, Stefano GB (2003) Molecular identification and functional expression of mu 3, a novel alternatively spliced variant of the human mu opiate receptor gene. J Immunol 170:5118–5123
Cassuto J, Sinclair R, Bondorevic M et al (2006) Anti-inflammatory properties of local anesthetics and their present and potential clinical implications. Acta Anaesthesiol Scand 50(3):265–282
Chambrier C, Chassard D, Bienvenu J et al (1996) Cytokine and hormonal changes after cholecystectomy: effect of ibuprofen pretreatment. Ann Surg 224:178–182
Christopherson R, Beattie C, Frank SM et al (1993) Perioperative morbidity in patients randomized to epidural or general anesthesia for lower extremity vascular surgery. Perioperative Ischemia Randomized Anesthesia Trial Study Group. Anesthesiology 79:422–434
Christopherson R, James KE, Tableman M et al (2008) Long-term survival after colon cancer surgery: a variation associated with choice of anesthesia. Anesth Analg 107:325–332
Coderre TJ, Katz J, Vaccarino AL, Melzack R et al (1993) Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 52:259–285
Delogu G, Moretti S, Antonucci A et al (2004) Apoptogenic effect of fentanyl on freshly isolated peripheral blood lymphocytes. J Trauma 57:75–81
Demicheli R, Miceli R, Moliterni A et al (2005) Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process. Ann Oncol 16:1449–1457
Dunn GP, Old LJ, Schreiber RD (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21:137–148
Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES et al (2000) The sympathetic nerve – an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 52:595–638
Exadaktylos AK, Buggy DJ, Moriarty DC et al (2006) Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology 105:660–664
Faist E, Ertel W, Cohnert T et al (1990) Immunoprotective effects of cyclooxygenase inhibition in patients with major surgical trauma. J Trauma 30:8–17
Faist E, Schinkel C, Zimmer S et al (1996) Update on the mechanisms of immune suppression of injury and immune modulation. World J Surg 20:454–459
Farooqui M, Li Y, Rogers T et al (2007) COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. Br J Cancer 97:1523–1531
Fleischmann E, Marschalek C, Schlemitz K et al (2009) Nitrous oxide may not increase the risk of cancer recurrence after colorectal surgery: a follow-up of a randomized controlled trial. BMC Anesthesiol 9:1
Forget P, De Kock M (2009) Could anaesthesia, analgesia and sympathetic modulation affect neoplasic recurrence after surgery? A systematic review centred over the modulation of natural killer cells activity. Ann Fr Anesth Reanim 28:751–768
Forget P, Vendenhende J, Berliere M et al (2010) Do intraoperative analgesics influence breast cancer recurrence after mastectomy? A retrospective analysis. Anesth Analg 110:1630–1635
Forget P, Tombal B, Scholtes JL et al (2011) Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer? Eur J Anaesthesiol 28:830–835
Fuggetta MP, Di Francesco P, Falchetti R et al (2005) Effect of morphine on cell-mediated immune responses of human lymphocytes against allogeneic malignant cells. J Exp Clin Cancer Res 24:255–263
Glasner A, Avraham R, Rosenne E et al (2011) Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor. J Immunol 184:2449–2457
Goldfarb Y, Ben-Eliyahu S (2006) Surgery as a risk factor for breast cancer recurrence and metastasis: mediating mechanisms and clinical prophylactic approaches. Breast Dis 26:99–114
Gottschalk A, Ford JG, Reglin CC et al (2010a) Association between epidural analgesia and cancer recurrence after colorectal cancer surgery. Anesthesiology 113:27–34
Gottschalk A, Sharma S, Ford JG et al (2010b) Review article: the role of the perioperative period in recurrence after cancer surgery. Anesth Analg 110:1636–1643
Gupta K, Kshirsagar S, Chang L et al (2002) Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res 62:4491–4498
Gupta A, Bjornsson A, Fredriksson M et al (2011) Reduction in mortality after epidural anaesthesia and analgesia in patients undergoing rectal but not colonic cancer surgery: a retrospective analysis of data from 655 patients in central Sweden. Br J Anaesth 107:164–170
Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70
Hengartner MO (2000) The biochemistry of apoptosis. Nature 407:770–776
Hollmann MW, Gross A, Jelacin A, Durieux ME (2001) Local anesthetic effects on priming and activation of human neutrophils. Anesthesiology 95:113–122
Hong JY, Lim KT (2008) Effect of preemptive epidural analgesia on cytokine response and postoperative pain in laparoscopic radical hysterectomy for cervical cancer. Reg Anesth Pain Med 33:44–51
Iglesias M, Segura MF, Comella JX, Olmos G (2003) Mu-opioid receptor activation prevents apoptosis following serum withdrawal in differentiated SH-SY5Y cells and cortical neurons via phosphatidylinositol 3-kinase. Neuropharmacology 44:482–492
Ismail H, Ho KM, Narayan K, Kondalsamy-Chennakesavan S (2010) Effect of neuraxial anaesthesia on tumour progression in cervical cancer patients treated with brachytherapy: a retrospective cohort study. Br J Anaesth 105:145–149
Keh D, Boehnke T, Weber-Cartens S et al (2003) Immunologic and hemodynamic effects of “low-dose” hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 167:512–520
Kehlet H (1989) The stress response to surgery: release mechanisms and the modifying effect of pain relief. Acta Chir Scand Suppl 550:22–28
Kelly G, Strasser A (2011) The essential role of evasion from cell death in cancer. Adv Cancer Res 111:39–96
Koodie L, Ramakrishnan S, Roy S (2010) Morphine suppresses tumor angiogenesis through a HIF-1alpha/p38MAPK pathway. Am J Pathol 177:984–997
Kundu JK, Surh YJ (2008) Inflammation: gearing the journey to cancer. Mutat Res 659:15–30
Kurosawa S, Kato M (2008) Anesthetics, immune cells, and immune responses. J Anesth 22:263–277
Lai R, Peng Z, Chen D et al (2012) The effects of anesthetic technique on cancer recurrence in percutaneous radiofrequency ablation of small hepatocellular carcinoma. Anesth-Analg 114:290–296
Landen CN, Lin YG, Amaiz Pena GN et al (2007) Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer. Cancer Res 67:10389–10396
Leo S, Nuydens R, Meert TF (2009) Opioid-induced proliferation of vascular endothelial cells. J Pain Res 2:59–66
Lewis JW, Shavit Y, Terman GW et al (1983) Apparent involvement of opioid peptides in stress-induced enhancement of tumor growth. Peptides 4:635–638
Lin X, Wang YJ, Li Q et al (2009) Chronic high-dose morphine treatment promotes SH-SY5Y cell apoptosis via c-Jun N-terminal kinase-mediated activation of mitochondria-dependent pathway. FEBS J 276:2022–2036
Lin L, Liu C, Tan H et al (2011) Anaesthetic technique may affect the prognosis for ovarian serous adenocarcinoma: a retrospective analysis. Br J Anaesth 108:814–822
Lutgendorf SK, Cole S, Costanzo E et al (2003) Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin Cancer Res 9:4514–4521
MacGregor RR, Thorner RE, Wright DM (1980) Lidocaine inhibits granulocyte adherence and prevents granulocyte delivery to inflammatory sites. Blood 56:203–209
Magnusdottir H, Kirno K, Ricksten SE, Elam M (1999) High thoracic epidural anesthesia does not inhibit sympathetic nerve activity in the lower extremities. Anesthesiology 91:1299–1304
Marx J (2008) Cancer biology. All in the stroma: cancer’s Cosa Nostra. Science 320:38–41
Masur K, Niggemann B, Zanker KS, Entschladen F (2001) Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. Cancer Res 61(7):2866–2869
McMillan DC, Wotherspoon HA, Fearon KC et al (1995) A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg 170:319–322
Melamed R, Rosenne E, Shakhar K et al (2005) Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor. Brain Behav Immun 19:114–126
Melchi CF, Mele A, Baliva G et al (1995) Prognostic value of anesthesia type for patients treated for cutaneous melanoma. Dermatol Surg 21:786–788
Mellon RD, Bayer BM (1998) Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity. Brain Res 789:56–67
Mikawa K, Akamarsu H, Nishina K et al (2003) Effects of ropivacaine on human neutrophil function: comparison with bupivacaine and lidocaine. Eur J Anaesthesiol 20:104–110
Moss J, Rosow CE (2008) Development of peripheral opioid antagonists’ new insights into opioid effects. Mayo Clin Proc 83:1116–1130
Myles PS, Peyton P, Silbert B et al (2011) Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: randomised trial. BMJ 342:d1491
Oliveira GS, Ahmad S, Schink J et al (2011) Intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free survival in ovarian cancer patients after primary cytoreductive surgery. Reg Anesth Pain Med 36:271–277
Page GG (2005) Surgery-induced immunosuppression and postoperative pain management. AACN Clin Issues 16:302–309 (quiz 416–418)
Pasi A, Qu BX, Steiner R (1991) Angiogenesis: modulation with opioids. Gen Pharmacol 22:1077–1079
Pera M, Nelson H, Rajkumar SV et al (2003) Influence of postoperative acute-phase response on angiogenesis and tumor growth: open vs. laparoscopic-assisted surgery in mice. J Gastrointest Surg 7:783–790
Raven R (1990) The theory and practice of oncology: historical evolution and present principles. Parthenon Publishing Group, Park Ridge
Reiche EMV, Nunes SO, Morimoto HK (2004) Stress, depression, the immune system, and cancer. Lancet Oncol 5:617–625
Rosenberg SA, Lotze MT, Yang JC et al (1993) Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer. J Natl Cancer Inst 85:622–632
Sacerdote P (2008) Opioid-induced immunosuppression. Curr Opin Support Palliat Care 2:14–18
Sacerdote P, Manfredi B, Bianchi M et al (1994) Intermitent but not continuous inescapable footshock stress affects immune response and immunocyte beta-endorphin concentration in the rats. Brain Behav Immun 8:251–260
Sacerdote P, Bianchi M, Gaspani L et al (2000) The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients. Anesth Analg 90:1411–1414
Salo M (1996) Cytokines and attenuation of response to surgery. Acta Anaesthesiol Scan 40(2):141–142
Schlagenhauff B, Ellwanger U, Breuninger H, et al (2000) Prognostic impact of the type of anesthesia used during the excision of primary cutaneous melanoma. Melanoma Res 10(2):165–169
Schmidt W, Schmidt H, Bauer H et al (1997) Influence of lidocaine on endotoxin-induced leukocyte-endothelial cell adhesion and macromolecular leakage in vivo. Anesthesiology 87(3):617–624
Seebacher C, Heubaum F, Kuster P et al (1990) Comparative analysis of narcosis and local anesthesia in surgery of malignant melanoma of skin. Hautarzt 41:137–141
Shavit Y, Martin FC, Yirmiya R et al (1987) Effects of single administration of morphine or footshock stress on natural killer cell cytotoxicity. Brain Behav Immun 1:318–328
Sinclair R, Eriksson AS, Gretzer C et al (1993) Inhibitory effects of amide local anaesthetics on stimulus-induced human leukocyte metabolic activation, LTB4 release and IL-1 secretion in vitro. Acta Anaesthesiol Scand 37:159–165
Snyder GL, Greenberg S (2010) Effect of anaesthetic technique and other perioperative factors on cancer recurrence. Br J Anaesth 105:106–115
Stein C, Rosow CE (2004) Analgesics: receptor ligands and opiate narcotics. In: Evers AS, Maze M (eds) Anesthetic pharmacology: physiologic principles and clinical practice. Churchill Livingstone, Philadelphia
Sueoka E, Sueoka N, Kai Y et al (1998) Anticancer activity of morphine and its synthetic derivative, KT-90, mediated through apoptosis and inhibition of NF-kappaB activation. Biochem Biophys Res Commun 252:566–570
Tegeder I, Grosch S, Schmidtko A et al (2003) G protein-independent G1 cell cycle block and apoptosis with morphine in adenocarcinoma cells: involvement of p53 phosphorylation. Cancer Res 63(8):1846–1852
Thaker PH, Han LY, Kamat AA et al (2006) Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 12:939–944
Tsui BC, Rashiq S, Schoplfocher D et al (2010) Epidural anesthesia and cancer recurrence rates after radical prostatectomy. Can J Anaesth 57:107–112
Vallejo R, de Leon-Casasola O, Ramsun B (2004) Opioid therapy and immunosuppression: a review. Am J Ther 11:54–65
Wada H, Seki S, Takahashi T et al (2007) Combined spinal and general anesthesia attenuates liver metastasis by preserving TH1/TH2 cytokine balance. Anesthesiology 106:499–506
Welters I, Menzebach A, Goumon Y et al (2000) Morphine inhibits NF-kappaB nuclear binding in human neutrophils and monocytes by a nitric oxide-dependent mechanism. Anesthesiology 92:1677–1684
Wuethrich PY, Hsu Schmitz SF, Kessler TM et al (2011) Potential influence of the anesthetic technique used during open radical prostatectomy on prostate cancer-related outcome: a retrospective study. Anesthesiology 113:570–576
Yamashita JI, Kurusu Y, Fujino N et al (2000) Detection of circulating tumor cells in patients with non-small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: a potential hazard for intraoperative hematogenous tumor cell dissemination. J Thorac Cardiovasc Surg 119:899–905
Yanagi H, Sankawa H, Saito H, Likura Y (1996) Effect of lidocaine on histamine release and Ca2+ mobilization from mast cells and basophils. Acta Anaesthesiol Scand 40:1138–1144
Yang EV, Sood AK, Chen M et al (2006) Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res 66:10357–10364
Yardeni IZ, Beilin B, Mayburd E et al (2009) The effect of perioperative intravenous lidocaine on postoperative pain and immune function. Anesth Analg 109:1464–1469
Yeager MP, Colacchio TA, Yu CT et al (1995) Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology 83:500–508
Yeager MP, Procopio MA, DeLeo JA et al (2002) Intravenous fentanyl increases natural killer cell cytotoxicity and circulating CD16 (+) lymphocytes in humans. Anesth Analg 94:94–99
Yin D, Mufson RA, Wang R, Shi Y (1999) Fas-mediated cell death promoted by opioids. Nature 397:218
Yoshida AS, Tokuyama S, Iwamura T, Ueda H (2000) Opioid analgesic-induced apoptosis and caspase-independent cell death in human lung carcinoma A549 cells. Int J Mol Med 6:329–335
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Shilling, A.M., Tiouririne, M. (2013). Perioperative Morphine and Cancer Recurrence. In: Parat, MO. (eds) Morphine and Metastasis. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-5678-6_9
Download citation
DOI: https://doi.org/10.1007/978-94-007-5678-6_9
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-5677-9
Online ISBN: 978-94-007-5678-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)